Ⅳ型镶嵌式外固定器治疗下肢长骨骨缺损

目的：探讨应用IV型镶嵌式外固定器治疗下肢长骨骨缺损的临床疗效。方法：1996年4月～2008年4月应用IV型镶嵌式外固定器治疗下肢长骨骨缺损48例患者,其中股骨8例,胫骨40例。骨缺损长度为5～15cm,平均8cm。随访时间9-27个月,平均18个月。结果：48例患者肢体长度均得到恢复;骨缺损达到骨性愈合,平均愈合时间8.2个月;6例骨折成角,均〈10°;12例共25处针孔感染;所有病例无神经血管损伤表现,髋、膝、踝关节活动均未受影响。结论：IV型镶嵌式外固定器是治疗长骨复杂骨缺损、成功重建肢体长度的有效方法。     

成年犬股骨微波灭活骨缺损模型的建立

目的　建立成年犬股骨微波灭活骨缺损的实验动物模型 ,为骨缺损修复的研究提供实验依据。方法应用自行研制的骨肿瘤微波治疗仪 ,以 1 5kHz频率、70W功率加热至 5 0～ 5 5℃ ,维持 2 0min ,造成犬股骨中段不同大小的骨缺损。结果　在保持犬股骨连续性的前提下 ,长度 1 5cm的骨缺损 9个月时有 1 2被新生骨填充 ,长度2 5cm和 3 5cm的骨缺损 9个月时无愈合倾向 ,但后者骨折的发生率高。结论　成年犬股骨微波高温造成的骨缺损 ,长 2 5cm、宽 1 0cm 9个月不能自愈 ,适宜于各种骨修复材料的填充 ,是理想的实验模型     

IV型镶嵌式外固定器治疗下肢长骨骨缺损

目的:探讨应用IV型镶嵌式外固定器治疗下肢长骨骨缺损的临床疗效.方法:1996年4月～2008年4月应用IV型镶嵌式外固定器治疗下肢长骨骨缺损48例患者,其中股骨8例,胫骨40例.骨缺损长度为5～15cm,平均8cm.随访时间9-27个月,平均18个月.结果:48例患者肢体长度均得到恢复;骨缺损达到骨性愈合,平均愈合时间8.2个月;6例骨折成角,均<10°;12例共25处针孔感染;所有病例无神经血管损伤表现,髋、膝、踝关节活动均未受影响.结论:IV型镶嵌式外固定器是治疗长骨复杂骨缺损、成功重建肢体长度的有效方法.     

皮瓣移植结合骨牵张技术修复感染性胫骨复合皮肤组织缺损的临床效果观察

目的：观察皮瓣移植结合骨牵张技术修复感染性胫骨复合皮肤组织缺损的临床效果。方法：自2008年6月至2012年6月,共收治了胫骨感染性复合组织缺损16例,采用一期彻底去除病变坏死组织和病变的胫骨断端,切取同侧腓肠肌皮瓣、腓肠神经营养血管皮瓣转位、对侧小腿内侧皮瓣和游离皮瓣移植修复小腿皮肤缺损,二期行骨牵张延长术进行治疗。结果：所有16例胫骨复合组织缺损病例感染均得到了控制,移植的皮瓣顺利成活,胫骨截骨延长区成骨良好,断端骨愈合,其中2例出现针道感染,无血管神经并发症发生。骨延长2～9cm,平均延长5．5cm。外同定延长支架在停止骨延长8-20个月后拆除,双下肢等长,膝关节和踝关节功能良好。术后细菌培养＋药敏结果：金黄色葡萄球菌感染8例,表皮葡萄球菌感染4例,大肠杆菌感染1例,阴沟肠杆菌感染l例,肠球菌感染l例。结论：伤口彻底清创,胫骨断端坏死骨切除后一期行皮瓣移植,二期行骨牵张延长术是一种治疗感染性胫骨复合组织缺损的有效方法。     

病灶清除植骨联合DHS内固定治疗股骨近端囊肿

目的:探讨病灶清除植骨联合动力髋螺钉(DHS)内固定术治疗股骨近端囊肿的临床疗效及意义。方法:自2006年3月至2012年6月共有17例股骨近端囊肿患者在我院接受治疗并有完整随访,全部患者均应用病灶清除植骨联合DHS内固定术手术治疗。结果:平均随访时间18个月(14-60个月),病灶植骨处平均愈合时间7个月(6-8个月)。平均手术时间182分钟(90分钟~282分钟),术中平均出血量340 mL(100~700 mL)。切口全部一期愈合,术后病灶处均达到骨性愈合,骨密度均匀,17例均未出现骨囊肿复发及内固定断裂,未发生股骨头坏死及股骨近端骨折,按Harris髋关节功能评分标准,优良率为100%。结论:病灶清除植骨术联合DHS内固定治疗股骨近端囊肿操作简单,术中出血少,并发症少,疗效确切,是治疗股骨近端骨囊肿,降低其复发率和预防病理性骨折的一种有效方法。     

镶嵌式外固定架治疗长骨骨不连17例体会

目的：探讨长骨骨不连的一种治疗方法。方法：2007年1月至2009年8月,采用镶嵌式外固定架治疗17例长骨骨不连。本组17例,男11例,女6例,年龄16-64岁,平均31岁。2例为血源性骨髓炎病理性骨折后,股骨、胫骨各1例;6例为创伤性骨髓炎后骨折不愈,肱骨1例,股骨1例,胫骨4例;9例为手术后无感染性骨不连,肱骨2例,股骨2例,胫骨5例;7例有不同程度畸形,6例有1.5-8cm骨短缩,其中2例同时行骨痂延长术。结果：全部病人均获随访,随访时间9-20个月,以1975年天津全国骨科会议制定的骨折愈合标准为依据,本组17例病人均获得临床愈合,骨不连处平均愈合时间为4～9月（平均6.2月）,1例延长8cm,另1例延长6cm。结论：利用镶嵌式外固定架治疗长骨骨不连一种简单有效的方法。     

镶嵌式外固定架治疗长骨骨不连17例体会

目的:探讨长骨骨不连的一种治疗方法。方法:2007年1月至2009年8月,采用镶嵌式外固定架治疗17例长骨骨不连。本组17例,男11例,女6例,年龄16-64岁,平均31岁。2例为血源性骨髓炎病理性骨折后,股骨、胫骨各1例;6例为创伤性骨髓炎后骨折不愈,肱骨1例,股骨1例,胫骨4例;9例为手术后无感染性骨不连,肱骨2例,股骨2例,胫骨5例;7例有不同程度畸形,6例有1.5-8cm骨短缩,其中2例同时行骨痂延长术。结果:全部病人均获随访,随访时间9-20个月,以1975年天津全国骨科会议制定的骨折愈合标准为依据,本组17例病人均获得临床愈合,骨不连处平均愈合时间为4～9月(平均6.2月),1例延长8cm,另1例延长6cm。结论:利用镶嵌式外固定架治疗长骨骨不连一种简单有效的方法。     

15例腓肠肌岛状穿支肌皮瓣修复胫骨近端骨髓炎伴骨外露的临床观察

目的:观察腓肠肌岛状穿支肌皮瓣治疗胫骨近端骨髓炎伴骨外露的临床效果。方法:回顾性分析2013年1月至2015年6月在我科收治的15例胫骨近端骨髓炎伴骨外露患者,采用彻底清创、腓肠肌岛状穿支肌皮瓣进行修复治疗,皮肤缺损面积为5cm×4 cm~8 cm×6 cm,切取皮瓣面积为6 cm×5cm~9 cm×7 cm。术后对皮瓣成活率、并发症、膝踝关节功能、皮瓣外观满意度进行随访观察。结果:本组15例中14例肌皮瓣一期愈合,1例二期愈合,术后随访6~18个月无感染复发病例,膝踝关节功能良好。根据改良ASAMI评分系统评价疗效:优10例,良4例,中1例,差0例。结论:腓肠肌岛状穿支肌皮瓣修复胫骨近端骨髓炎伴骨外露具有良好疗效。     

DEXA对骨髓炎骨缺损治疗中骨痂密度的评价

目的：探讨DEXA对骨髓炎骨缺损治疗中骨痂密度的评价及意义。方法：严格按照纳入排除标准,选取21例骨髓炎清创后伴大段皮质骨缺损一期植骨的病人。术后4,6,8,10个月后对骨折端骨痂行双能X线骨密度仪检测,并进行X摄片以及Enneking评分,从而明确植骨区愈合骨痂的密度变化趋势,骨愈合情况以及症状改善情况。结果：（1）X线摄片结果显示：4个月后：骨缺损区依然清晰可见,内有少量稀疏骨痂通过,少量外骨痂形成。6个月后：植骨区内骨痂含量明显增多,且外骨痂膨大。8个月：缺损区模糊,有较致密骨痂生成,且外骨痂逐渐减少。10个月：植骨区骨痂更加致密,且部份髓腔再通。（2）Enneking评分：患者术后第10个月功能恢复情况评估正常功能20例,20分以下的患者1例。（3）BMD测定：骨折端的骨密度及骨密度比率随时间延长而增加,植骨10个月后患侧的骨密度已可基本上达到正常对照侧的骨密度水平。结论：双能X线骨密度测量从一定程度上反映出骨痂的力学强度特性。在感染性骨缺损治疗中可以作为检测植骨区的恢复情况的参考。     

微波高温灭活及自体髂骨异体骨粒复合骨水泥修复治疗长骨骨巨细胞瘤骨缺损

目的：探讨微波高温灭活及自体髂骨、异体骨粒复合骨水泥修复骨巨细胞瘤病灶刮除后骨缺损的临床应用效果。方法：应用原位分离插入式微波天线高温灭活技术,自体髂骨、异体骨粒复合骨水泥修复21例长骨骨巨细胞瘤术后骨缺损,从手术技术、肿瘤复发情况、肢体关节功能等方面全面综合评价此方法临床应用效果。结果：21例患者均获得骨性愈合,无骨折及内固定断裂发生,2例复发,复发率9.8%;肢体关节功能优18例（85.7%）、良3例（14.3%）、中差0例。结论：微波高温能彻底杀灭肿瘤组织降低复发率,自体髂骨保证与近关节软骨下骨愈合,异体骨粒复合骨水泥能良好充填残余瘤腔、且具有良好的生物力学性能,以防发生关节软骨面塌陷。     

Transarticular bony defects after trauma and sepsis: arthrodesis using vascularized fibular transfer

Ten male patients with previously infected bony defects involving both sides of an articulation underwent arthrodesis using a vascularized fibular transfer. The average age of these patients was 38 years (range, 20 to 60 years). The size of the bony defect averaged 9 cm (range, 3 to 21 cm). The ankle was involved in five patients, the knee in two patients, the wrist in two patients, and the elbow in one patient. Nine cases represented septic pseudarthroses (eight after trauma and one after attempted ankle arthrodesis). One patient had a defect across the wrist after debridement of a chronic infection. The patients were followed for an average of 71 months (range, 26 to 144 months). Nine patients healed after the index vascularized fibular transfer, and one patient (ankle arthrodesis) required a second cancellous bone-grafting procedure for delayed union at the junction of the fibula with the talus. Four of seven patients with lower limb involvement had residual leg length discrepancies averaging 5 cm (range, 3 to 8 cm), and one had a persistent 20-degree internal rotation deformity. Two of the patients with upper limb involvement had stiff digits. Five of the nine previously employed patients returned to their former occupation (including heavy labor in four cases). Complications included two wound separations, one case of instability of the donor ankle after removal of a large fibular graft (related in part to a prior injury), and one fracture at the junction of the fibular graft with the local bone 10 months after the index procedure, which united after plate fixation and application of autogenous cancellous bone graft. Arthrodesis using a transfer of vascularized fibular bone represents a viable option for limb salvage in the face of an infected transarticular bony defect.     

PRP 与CPC 应用于拔牙后种植位点保存的实验研究

目的:探讨磷酸钙骨水泥(CPC)与富血小板血浆(PRP)混合物应用于拔牙后种植位点保存的可行性。方法:拔除6只犬下颌双侧第三切牙与一侧第一切牙,并于每只犬的3个拔牙窝颊舌侧骨壁分别制造2 mm×2 mm×3 mm缺损,随机在两个牙槽窝内分别植入CPC或CPC与PRP的混合物,第三个不加处置作对照,在术后4、8、12周各处死两只动物,行大体、X线、显微镜观察,比较各组的新骨生成情况。结果:术后4周时CPC/PRP混合物组骨形成早于其他组,8、12周时CPC/PRP混合物组新骨生成明显优于CPC组和对照组。结论:CPC混合PRP可促牙槽窝新骨生成并能保证成骨的高度和颊舌向宽度,从而为后期种植义齿修复提供了必要的条件。     

Ectopic study of tissue-engineered bone complex with enamel matrix proteins, bone marrow stromal cells in porous calcium phosphate cement scaffolds, in nude mice

Objective: This study aimed to investigate the potential of enamel matrix proteins (EMPs) on promoting osteogenic differentiation of porcine bone marrow stromal cells (pBMSCs), as well as new bone formation capabilities, in a tissue‐engineered bone complex scaffold of EMPs, pBMSCs and porous calcium phosphate cement (CPC). Materials and methods: Effects of EMPs on pBMSCs in vitro was first determined by alkaline phosphatase (ALP) activity, von Kossa staining assay and mRNA expression of ALP, bone sialoprotein (BSP) and osteocalcin (OCN) genes. Next, an ectopic new bone formation test was performed in a nude mouse model with four groups: CPC scaffold alone; CPC scaffold + EMPs; CPC scaffold + pBMSCs; and CPC scaffold + EMPs + pBMSCs, for 2 or 4 weeks. Results: ALP activity, von Kossa assay and mRNA expressions of ALP, BSP and OCN genes were all significantly higher with 150 μg/ml EMP treatment in vitro. In nude mice, new bone formation was detected only in the CPC scaffold + EMPs + pBMSCs group at 2 weeks. At 4 weeks, in the tissue‐engineered construct there was significantly higher bone formation ability than other groups. Conclusions: EMPs promoted osteogenic differentiation of pBMSCs, and the tissue‐engineered complex of EMPs, pBMSCs and CPC scaffold may be a valuable alternative to be used in periodontal bone tissue engineering and regeneration.     

Mechanical behavior of a new biphasic calcium phosphate bone graft

The aim of this study was to create a new porous calcium phosphate implant for use as a synthetic bone graft substitute. Porous bioceramic was fabricated using a foam-casting method. By using polyurethane foam and a slurry containing hydroxyapatite-dicalcium phosphate powder, water, and additives, a highly porous structure (66 ± 5%) was created. The porous specimens possess an elastic modulus of 330 ± 32 MPa and a compressive strength of 10.3 ± 1.7 MPa. The X-ray diffraction patterns show hydroxyapatite and beta-pyrophosphate phases after sintering. A rabbit model was developed to evaluate the compressive strength and elastic modulus of cancellous bone defects treated with these porous synthetic implants. The compressive mechanical properties became weaker until the second month post implantation. After the second month, these properties increased slightly and remained higher than control values. New bone formed on the outside surface and on the macropore walls of the specimens, as osteoids and osteoclasts were evident two months postoperatively. Considering these properties, these synthetic porous calcium phosphate implants could be applicable as cancellous bone substitutes.     

万古霉素/磷酸钙骨水泥复合材料的细胞毒性研究

目的:研究不同浓度配比(0%、1%、5%、10%)万古霉素/磷酸钙复合材料对大鼠骨髓间充质干细胞的毒性作用。方法:原代培养大鼠间充质干细胞并鉴定;采用CCK-8法测定不同浓度配比万古霉素/磷酸钙复合材料对大鼠骨髓间充质干细胞增殖的影响、TUNEL法测定细胞凋亡率、扫描电镜观察细胞形态学改变。结果:CCK-8结果显示,5%及10%万古霉素/磷酸钙复合材料显著抑制大鼠骨髓间充质干细胞增殖(P0.05);TUNEL结果显示,5%及10%万古霉素/磷酸钙复合材料组细胞凋亡率显著增高(P0.05);扫描电镜结果显示,高浓度万古霉素毒性作用下细胞失活,形态学发生显著变化;1%万古霉素/磷酸钙复合材料组对细胞影响相对于空白对照组无显著差异。结论:低浓度(1%)万古霉素/磷酸钙复合材料基本无细胞毒性,细胞相容性好。     

带腓肠腱膜的腓肠神经营养皮瓣修复KuwadeⅣ型跟腱缺损

目的:回顾性分析带腓肠肌腱膜的腓肠神经营养皮瓣修复KuwadeⅣ型跟腱缺损的临床病例,探讨其手术注意事项及治疗经验。方法:总结2008年5月-2013年8月收治的KuwadeⅣ型跟腱缺损19例,应用带腓肠肌腱膜的腓肠神经营养皮瓣进行一期修复。7例为新鲜损伤,12例为陈旧性缺损。19例跟腱缺损均伴有皮肤及软组织坏死,皮肤缺损范围为4.0 cm×6.0 cm-6.0cm×12.0 cm,跟腱缺损长度为5-9 cm,术中皮瓣切取范围为6.0 cm×5.5 cm-12.0 cm×8.0cm,腓肠腱膜切取范围5.5 cm×6.0cm-10.0 cm×6.0 cm;供区游离植皮修复。客观性评价指标包括关节跖屈、背伸动度及形态学,主观性评价采用AOFAS评分。结果:术后17例跟腱功能重建良好,2例感染控制不良,跟腱移植体部分坏死。皮瓣完全成活13例,创面Ⅰ期愈合。2例术后6天皮瓣远端表皮坏死,经换药后愈合。2例术后10天皮瓣远端部分坏死,经局部皮瓣移位修复愈合,2例感染控制不良者,皮瓣未愈合,移植跟腱部分坏死,经再次清创后,行阔筋膜条修复术,局部皮瓣移位修复。术后19例均获随访,随访时间6~24个月,平均18个月。术后皮瓣略臃肿,但不影响穿鞋,行走功能恢复良好,术后1年AOFAS评分平均80.31分。结论:带腓肠肌腱膜的腓肠神经营养皮瓣用于治疗KuwadeⅣ型跟腱缺损,可以同时修复皮肤及跟腱缺损,是一种较为理想的一期修复方法。     

Applications of a new carbonated calcium phosphate bone cement: early experience in pediatric and adult craniofacial reconstruction

Hydroxyapatite cements have recently been employed as bone substitutes in craniofacial reconstruction. They are easily applied, nonresorbable, available in unlimited quantity, and eliminate donor-site morbidity. Norian CRS (craniofacial repair system) is a new carbonated calcium phosphate paste that is unique in that it more closely resembles bone than do traditional hydroxyapatite pastes. Norian is a low-order crystalline apatite soluble at a low pH, facilitating its resorption and replacement by host bone. The cement was first used for craniofacial surgery in North America at the Children's Hospital of Philadelphia. This report presents the authors' experience with this bone substitute in both pediatric and adult craniofacial reconstruction. Sixteen adult and pediatric patients underwent craniofacial reconstruction involving the use of carbonated calcium phosphate paste for correction of defects that required from 5 to 110 g of carbonated calcium phosphate paste (mean, 28.5 g). The patients were all followed for a minimum of 14 months. Minor complications included one case of infection and two cases involving cement microfragmentation. In the authors' experience, carbonated calcium phosphate paste has proved to be an excellent alloplastic material for osseous augmentation and reconstruction in the craniofacial skeleton. Few problems were encountered using this material; no significant morbidity was encountered. Although this material seems to be promising as a bone substitute, further follow-up will be necessary to evaluate its potential role in craniofacial surgery.